Nanoparticle based drug delivery system: Advantages and applications

Indian Journal of Science and Technology

Volumn 4, Issue 3, 2011, Pages 177-180

  Singh, Sandeep ^a   Pandey, Vivek Kumar ^a   Tewari, Ravi Prakash ^a   Agarwal, Vishnu ^a  

^a MOTILAL NEHRU NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Ceramic nanoparticles; Dendrimers; Drug delivery; Liposomes; Microbes; Polymeric nanoparticles

Indexed keywords

EID: 84867992991     PISSN: 09746846     EISSN: 09745645     Source Type: Journal    
DOI: 10.17485/ijst/2011/v4i3/29960     Document Type: Article

References (17)

1. Ahmad Z, Pandey R, Sharma S and Khuller GK (2006) Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Ind. J. Chest Dis. Allied. Sci. 48, 171-176.
2. Balogh L, Swanson DR, Tomalia DA, Hagnauer GL and McManus AT (2001) Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano. Lett. 1, 18-21.
3. Bawa R, Bawa SR and Meibius SB et al. (2005) Protecting new ideas and invention in nanomedicine via patent. Nanomedicine. 1(2), 150-158.
4. Davis ME, Chen ZG and Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature. 7, 771-782.
5. Devarakonda B, Hill RA, Liebenberg W, Brits M and de Villiers MM (2005) Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int. J. pharm. 304(1-2), 193-209.
6. Hughes GA (2005) Nanostructure-mediated drug delivery. Nanomedicine. 1, 22-30.
7. Jain N, Jain R, Thakur N, Gupta BP, Jain DK, Banveeri J and Jain S (2010) Nanotechnology: a safe and effective drug delivery system. Asian J. Pharm. Clin. Res. 3, Issue 3.
8. Omri A, Suntres ZE and Shek PN (2002) Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem. Pharmacol. 64, 1407-1413.
9. Pandey R and Khuller GK (2006) Oral nanoparticlebased antituberculosis drug delivery to the brain in an experimental model. J. Antimicrob. Chemotherapy. 57(6), 1146-1152.
10. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R and Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760.
11. Pragati S, Ashok S and Kuldeep S (2009) Recent advances in periodontal drug delivery systems. Int. J. D. Del. 1, 1-14.
12. Rao DP, Srivastav SK, Prasad C, Saxena R and Asthana S (2010) Role of nanoparticles in drug delivery. Int. J. Nanotech. App. 0973-631X Volume 4.
13. Schumacher I and Margalit R (1997) Liposomeencapsulated ampicillin: physicochemical and antibacterial properties. J. Pham. Sci. 86, 635-641.
14. Wadher K, Kalsait R and Umekar M (2009) Alternate drug delivery system: recent advancement and future challenges. Arch. Pharm. Sci. Res. 1 No. 2, 97-105.
15. Yih TC and Al-Fandi M (2006) Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 97, 1184-1190.
16. Zhang L, Gu FX, Chan JM, Wang AZ, Langer R.S and Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83(5), 761-769.
17. Zhang L, Pornpattananangkul D, Hu CMJ and Huang CM (2010) Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem.17, 585-594.